Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-17,064
Closed -$170K 345
2023
Q2
$170K Sell
17,064
-966
-5% -$9.23K 0.01% 334
2023
Q1
$173K Sell
18,030
-377
-2% -$4.18K 0.02% 332
2022
Q4
$205K Buy
18,407
+255
+1% +$2.67K 0.02% 320
2022
Q3
$154K Buy
18,152
+263
+1% +$2.59K 0.02% 310
2022
Q2
$187K Sell
17,889
-482
-3% -$5.28K 0.03% 183
2022
Q1
$200K Sell
18,371
-337
-2% -$4.44K 0.02% 190
2021
Q4
$253K Sell
18,708
-111
-0.6% -$1.48K 0.03% 176
2021
Q3
$255K Buy
18,819
+817
+5% +$11.6K 0.04% 174
2021
Q2
$257K Sell
18,002
-2,288
-11% -$33.1K 0.04% 172
2021
Q1
$284K Sell
20,290
-798
-4% -$13K 0.04% 171
2020
Q4
$395K Buy
+21,088
New +$344K 0.06% 158

Other funds holding VTRS

Cadence Bank's VTRS Position: Q3 2023 in Review

Cadence Bank sold out of Viatris (VTRS) in Q3 2023, closing a stake of 17,064 shares — an estimated $170K sold.

Cadence Bank first reported a position in VTRS in Q4 2020 and held it in 11 quarters. The position peaked at $395K in Q4 2020. 960 funds tracked by Wall St. Rank hold VTRS as of Q3 2023.

  • Cadence Bank reported no remaining Viatris position as of Q3 2023 after selling out during the quarter.
  • Cadence Bank sold 17,064 Viatris shares in Q3 2023, an estimated $170K.
  • Cadence Bank first reported a position in Viatris in Q4 2020 and held it in 11 quarters.
  • Cadence Bank's Viatris position peaked at $395K in Q4 2020.
  • 960 funds tracked by Wall St. Rank held Viatris as of Q3 2023.

Based on Cadence Bank's 13F filing for Q3 2023, filed 13 Nov 2023.